LENSAR, Inc. (LNSR)
USD 14.06
(-0.28%)
USD 14.06
(-0.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -8.71 Million USD | 54.21% |
| 2022 | -16.77 Million USD | -3.64% |
| 2021 | -16.88 Million USD | -6.89% |
| 2020 | -15.86 Million USD | -95.43% |
| 2019 | -8.79 Million USD | -85.99% |
| 2018 | -4.66 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.92 Million USD | 35.74% |
| 2024 Q2 | -653 Thousand USD | 66.15% |
| 2023 Q2 | 3.4 Million USD | 183.35% |
| 2023 Q1 | -4.08 Million USD | -74.8% |
| 2023 FY | - USD | 54.21% |
| 2023 Q4 | -2.03 Million USD | 62.97% |
| 2023 Q3 | -5.5 Million USD | -261.56% |
| 2022 Q3 | -3.23 Million USD | 50.3% |
| 2022 Q2 | -6.51 Million USD | -2.15% |
| 2022 Q1 | -6.37 Million USD | -77.4% |
| 2022 FY | - USD | -3.64% |
| 2022 Q4 | -2.33 Million USD | 27.78% |
| 2021 Q2 | -3.71 Million USD | 18.28% |
| 2021 Q3 | -5.45 Million USD | -46.94% |
| 2021 Q4 | -3.59 Million USD | 34.11% |
| 2021 FY | - USD | -6.89% |
| 2021 Q1 | -4.54 Million USD | 30.31% |
| 2020 FY | - USD | -95.43% |
| 2020 Q1 | -2.28 Million USD | -118.11% |
| 2020 Q4 | -6.51 Million USD | -48.6% |
| 2020 Q3 | -4.38 Million USD | -37.85% |
| 2020 Q2 | -3.18 Million USD | -39.03% |
| 2019 Q1 | -1.67 Million USD | 0.0% |
| 2019 Q2 | -1.67 Million USD | 0.0% |
| 2019 Q3 | -5 Million USD | -198.21% |
| 2019 Q4 | -1.04 Million USD | 79.05% |
| 2019 FY | - USD | -85.99% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 35.39% |
| Cerus Corporation | -26.53 Million USD | 67.162% |
| OrthoPediatrics Corp. | -8.38 Million USD | -3.973% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 16.966% |
| Talis Biomedical Corporation | -66.04 Million USD | 86.806% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 47.742% |
| Inogen, Inc. | -45.67 Million USD | 80.923% |
| Spectral AI, Inc. | -12.26 Million USD | 28.935% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 81.729% |
| CVRx, Inc. | -38.73 Million USD | 77.501% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -146.995% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 28.025% |
| Orthofix Medical Inc. | -86.98 Million USD | 89.982% |
| Venus Concept Inc. | -26.11 Million USD | 66.63% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 82.492% |
| Bioventus Inc. | -23.07 Million USD | 62.228% |
| BrainsWay Ltd. | -2.31 Million USD | -277.066% |
| Envoy Medical, Inc. | -18.23 Million USD | 52.221% |
| electroCore, Inc. | -17.76 Million USD | 50.935% |
| IceCure Medical Ltd | -15.25 Million USD | 42.87% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 82.485% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 48.302% |
| MaxCyte, Inc. | -44.12 Million USD | 80.253% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 25.876% |
| Nexalin Technology, Inc. | -5.69 Million USD | -53.091% |
| PAVmed Inc | -75.74 Million USD | 88.495% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 83.79% |
| RxSight, Inc. | -41.03 Million USD | 78.766% |
| Sight Sciences, Inc. | -49.41 Million USD | 82.366% |
| SI-BONE, Inc. | -34.44 Million USD | 74.702% |
| TELA Bio, Inc. | -40.63 Million USD | 78.554% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 85.053% |
| Treace Medical Concepts, Inc. | -39 Million USD | 77.661% |
| LivaNova PLC | 39.01 Million USD | 122.334% |
| 908 Devices Inc. | -34.02 Million USD | 74.389% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 92.121% |
| Nemaura Medical Inc. | -7.28 Million USD | -19.582% |
| NeuroPace, Inc. | -22.83 Million USD | 61.838% |
| Apyx Medical Corporation | -18.11 Million USD | 51.888% |
| Cutera, Inc. | -136.56 Million USD | 93.619% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -157.811% |
| BioSig Technologies, Inc. | -28.15 Million USD | 69.046% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 446.343% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 58.483% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 102.272% |
| Axonics, Inc. | 7.77 Million USD | 212.077% |
| Outset Medical, Inc. | -153.78 Million USD | 94.334% |
| IRIDEX Corporation | -7.44 Million USD | -16.998% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 91.117% |
| IRadimed Corporation | 20.8 Million USD | 141.893% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -8.087% |
| INVO Bioscience, Inc. | -6.88 Million USD | -26.657% |
| Telesis Bio, Inc. | -40.49 Million USD | 78.48% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 123.759% |
| Varex Imaging Corporation | 67.2 Million USD | 112.967% |
| Quipt Home Medical Corp. | 44.07 Million USD | 119.773% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 19.834% |
| Pulmonx Corporation | -55.09 Million USD | 84.183% |
| Dynatronics Corporation | -976 Thousand USD | -792.821% |
| Modular Medical, Inc. | -17.1 Million USD | 49.05% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 39.841% |
| Semler Scientific, Inc. | 23.58 Million USD | 136.941% |
| InMode Ltd. | 196.28 Million USD | 104.44% |
| Bruker Corporation | 599 Million USD | 101.455% |
| Cytosorbents Corporation | -28.81 Million USD | 69.754% |
| DexCom, Inc. | 916.7 Million USD | 100.951% |
| Align Technology, Inc. | 799.03 Million USD | 101.091% |
| Viveve Medical, Inc. | -20.61 Million USD | 57.734% |
| ZimVie Inc. | 91.07 Million USD | 109.568% |
| Movano Inc. | -29.12 Million USD | 70.081% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -97.686% |
| Nexalin Technology, Inc. | -5.69 Million USD | -53.091% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -146.995% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 95.523% |
| Profound Medical Corp. | -27.12 Million USD | 67.873% |
| Insulet Corporation | 323.6 Million USD | 102.693% |
| enVVeno Medical Corporation | -25.01 Million USD | 65.169% |
| Surmodics, Inc. | 1.18 Million USD | 833.502% |
| iCAD, Inc. | -6.56 Million USD | -32.734% |
| Nuwellis, Inc. | -16.35 Million USD | 46.723% |
| Biotricity, Inc. | -8.82 Million USD | 1.294% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 91.004% |
| Aethlon Medical, Inc. | -11.84 Million USD | 26.459% |
| InspireMD, Inc. | -20.91 Million USD | 58.328% |
| PAVmed Inc. | -75.74 Million USD | 88.495% |
| BIOLASE, Inc. | -15.13 Million USD | 42.44% |
| Beyond Air, Inc. | -59.03 Million USD | 85.238% |
| FONAR Corporation | 28.25 Million USD | 130.844% |
| AxoGen, Inc. | -13.32 Million USD | 34.619% |
| Vivani Medical, Inc. | -26.6 Million USD | 67.25% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 135.508% |
| Inari Medical, Inc. | 7.11 Million USD | 222.508% |
| UFP Technologies, Inc. | 72.74 Million USD | 111.979% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -157.37% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -41.553% |
| Tenon Medical, Inc. | -15.52 Million USD | 43.882% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 42.919% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 78.99% |
| AdaptHealth Corp. | -171.09 Million USD | 94.907% |
| Sintx Technologies, Inc. | -6.6 Million USD | -32.03% |
| NanoVibronix, Inc. | -3.43 Million USD | -153.683% |
| Quanterix Corporation | -38.08 Million USD | 77.121% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 19.834% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 29146.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 96.857% |
| TransMedics Group, Inc. | -7.6 Million USD | -14.613% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 59.963% |
| NeuroMetrix, Inc. | -7.09 Million USD | -22.805% |
| Hyperfine, Inc. | -47.06 Million USD | 81.484% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 85.055% |
| Biomerica, Inc. | -5.99 Million USD | -45.403% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1917.037% |
| AVITA Medical, Inc. | -39.56 Million USD | 77.977% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 5.003% |
| Silk Road Medical, Inc | -45.08 Million USD | 80.67% |